These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 8032706

  • 1. A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.
    Aoun M, Van der Auwera P, Varthalitis I, Bourguignon AM, Janssen M, Daneau D, Meunier F.
    Support Care Cancer; 1994 May; 2(3):191-6. PubMed ID: 8032706
    [Abstract] [Full Text] [Related]

  • 2. Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.
    Unal S, Hayran M, Tuncer S, Gür D, Uzun O, Akova M, Akalin HE.
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2898-900. PubMed ID: 9124864
    [Abstract] [Full Text] [Related]

  • 3. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE.
    Chemotherapy; 1998 Dec; 44(2):85-93. PubMed ID: 9551237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Use of fluoroquinolones in rheumatology].
    Belov BS, Shubin SV, Nasonova VA, Soldatova SI, Tarasova GM, Urumova MM, Ushakova MA, Anan'eva LP.
    Vestn Ross Akad Med Nauk; 1996 Dec; (12):12-5. PubMed ID: 9102072
    [Abstract] [Full Text] [Related]

  • 6. Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin.
    Tascini C, Gemignani G, Doria R, Biancofiore G, Urbani L, Mosca C, Malacarne P, Papineschi F, Passaglia C, Dal Canto L, Procaccini M, Furneri G, Didoni G, Filipponi F, Menichetti F.
    J Chemother; 2009 Jun; 21(3):311-6. PubMed ID: 19567352
    [Abstract] [Full Text] [Related]

  • 7. Activity of quinolones against gram-positive cocci: clinical features.
    Giamarellou H.
    Drugs; 1995 Jun; 49 Suppl 2():58-66. PubMed ID: 8549418
    [Abstract] [Full Text] [Related]

  • 8. [The clinical and microbiological study of the preparation perfloxacin in treating urologic infections].
    Dragiev D, Savov E, Lilov A, Tsenova Z, Saltirov I, Atanasova I.
    Khirurgiia (Sofiia); 1993 Jun; 46(4):49-51. PubMed ID: 8041098
    [Abstract] [Full Text] [Related]

  • 9. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP.
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [Abstract] [Full Text] [Related]

  • 10. Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial.
    López H, Li JZ, Balan DA, Willke RJ, Rittenhouse BE, Mozaffari E, Vidal G, Zitto T, Tang T.
    Clin Ther; 2003 Jun; 25(6):1846-71. PubMed ID: 12860502
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial.
    Weinberg WG.
    South Med J; 1993 Aug; 86(8):891-7. PubMed ID: 8351549
    [Abstract] [Full Text] [Related]

  • 12. Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].
    Cheong LL, Chan RK, Nadarajah M.
    Genitourin Med; 1992 Aug; 68(4):260-2. PubMed ID: 1328033
    [Abstract] [Full Text] [Related]

  • 13. [Clinical study of teicoplanin in the treatment of patients with gram-positive cocci: the Chinese experience].
    He LX, Pan J, Chen SY, Wang AX, Xie CM, Shen ZY.
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):337-41. PubMed ID: 16009001
    [Abstract] [Full Text] [Related]

  • 14. [Gram-positive cocci (include MRSA)].
    Tsuji A.
    Nihon Rinsho; 1994 Feb; 52(2):359-66. PubMed ID: 8126886
    [No Abstract] [Full Text] [Related]

  • 15. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R, Paganini H, Gómez S, Casimir L, Stamboulian D.
    Medicina (B Aires); 2002 Feb; 62 Suppl 2():48-51. PubMed ID: 12481489
    [Abstract] [Full Text] [Related]

  • 16. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V, Roilides E, Bibashi E, Gompakis N, Tsakiri A, Koliouskas D.
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [Abstract] [Full Text] [Related]

  • 17. A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
    Rolston KV, Nguyen H, Amos G, Elting L, Fainstein V, Bodey GP.
    J Infect Dis; 1994 Feb; 169(2):350-5. PubMed ID: 8106768
    [Abstract] [Full Text] [Related]

  • 18. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M, Nathwani D, Dryden M.
    J Antimicrob Chemother; 2004 Feb; 53(2):335-44. PubMed ID: 14729745
    [Abstract] [Full Text] [Related]

  • 19. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
    Martino P, Micozzi A, Gentile G, Raccah R, Girmenia C, Mandelli F.
    Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.
    Del Pozo JL, García Cenoz M, Hernáez S, Martínez A, Serrera A, Aguinaga A, Alonso M, Leiva J.
    Int J Antimicrob Agents; 2009 Nov; 34(5):482-5. PubMed ID: 19713086
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.